AD and psoriasis represent opposing extremes of Th2 cell dysregulation, and therefore we hypothesize that RAD50 polymorphisms might exert opposing effects on AD and psoriasis through variation in DNA repair resulting in a differential skew in Th2 cell response. This evidence concerns the gene RAD50 and psoriasis.